A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors
Clinical trial NCT05135975 · RECRUITING
Trial details
- NCT number
- NCT05135975
- Sponsor
- Nationwide Children's Hospital
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-20
- Primary completion
- 2026-07-01
- Enrollment
- 86
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.